hmmmm I don’t see there is much room here beyond black and white…
As is, the industry would compare to 2 fairly ill individuals that still manage… after the merger it would be like having one terminal patient, one with terminal brain cancer or the other with advance Alzheimer; a difference with no distinction at that point
hmmmm I don’t see there is much room here beyond black and white…
As is, the industry would compare to 2 fairly ill individuals that still manage… after the merger it would be like having one terminal patient, one with terminal brain cancer or the other with advance Alzheimer; a difference with no distinction at that point